APA

Ter Veer E., Prinsen H., Sprangers M. A. G., Zwinderman K. A. H., Bleijenberg G., van der Pouw Kraan T. C. T. M., de Vries I. J. M., Wierenga E. A. & van Laarhoven H. W. M. (20181015). Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial. : Cancer investigation.

Chicago

Ter Veer Emil, Prinsen Hetty, Sprangers Mirjam A G, Zwinderman Koos A H, Bleijenberg Gijs, van der Pouw Kraan Tineke C T M, de Vries I Jolanda M, Wierenga Eddy A and van Laarhoven Hanneke W M. 20181015. Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial. : Cancer investigation.

Harvard

Ter Veer E., Prinsen H., Sprangers M. A. G., Zwinderman K. A. H., Bleijenberg G., van der Pouw Kraan T. C. T. M., de Vries I. J. M., Wierenga E. A. and van Laarhoven H. W. M. (20181015). Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial. : Cancer investigation.

MLA

Ter Veer Emil, Prinsen Hetty, Sprangers Mirjam A G, Zwinderman Koos A H, Bleijenberg Gijs, van der Pouw Kraan Tineke C T M, de Vries I Jolanda M, Wierenga Eddy A and van Laarhoven Hanneke W M. Interferon Gamma-Induced Protein (IP-10) as Potential Biomarker for Cancer-Related-Fatigue: Results from a 6-month Randomized Controlled Trial. : Cancer investigation. 20181015.